Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2014

Open Access 01-12-2014 | Research

Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?

Authors: Harumi Jyonouchi, Lee Geng, Amy L Davidow

Published in: Journal of Neuroinflammation | Issue 1/2014

Login to get access

Abstract

Background

Some children with autism spectrum disorders (ASD) are characterized by fluctuating behavioral symptoms following immune insults, persistent gastrointestinal (GI) symptoms, and a lack of response to the first-line intervention measures. These children have been categorized as the ASD-inflammatory subtype (ASD-IS) for this study. We reported a high prevalence of non-IgE mediated food allergy (NFA) in young ASD children before, but not all ASD/NFA children reveal such clinical features of ASD-IS. This study addressed whether behavioral changes of ASD-IS are associated with innate immune abnormalities manifested in isolated peripheral blood (PB) monocytes (Mo), major innate immune cells in the PB.

Methods

This study includes three groups of ASD subjects (ASD-IS subjects (N = 24), ASD controls with a history of NFA (ASD/NFA (N = 20), and ASD/non-NFA controls (N = 20)) and three groups of non-ASD controls (non-ASD/NFA subjects (N = 16), those diagnosed with pediatric acute onset-neuropsychiatric syndrome (PANS, N = 18), and normal controls without NFA or PANS (N = 16)). Functions of purified PB Mo were assessed by measuring the production of inflammatory and counter-regulatory cytokines with or without stimuli of innate immunity (lipopolysaccharide (LPS), zymosan, CL097, and candida heat extracts as a source of β-lactam). In ASD-IS and PANS subjects, these assays were done in the state of behavioral exacerbation (`flare’) and in the stable (`non-flare’) condition. ASD-IS children in the `flare’ state revealed worsening irritability, lethargy and hyperactivity.

Results

`Flare’ ASD-IS PB Mo produced higher amounts of inflammatory cytokines (IL-1Β and IL-6) without stimuli than `non-flare’ ASD-IS cells. With zymosan, `flare’ ASD-IS cells produced more IL-1Β than most control cells, despite spontaneous production of large amounts of IL-1ß.. Moreover, `flare’ ASD-IS Mo produced less IL-10, a counterregulatory cytokine, in response to stimuli than `non-flare’ cells or other control cells. These changes were not observed in PANS cells.

Conclusions

We observed an imbalance in the production of inflammatory (IL-1ß and IL-6) and counterregulatory (IL-10) cytokines by `flare’ ASD-IS monocytes, which may indicate an association between intrinsic abnormalities of PB Mo and changes in behavioral symptoms in the ASD-IS subjects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jeste SS, Geschwind DH: Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol. 2014, 10: 74-81. 10.1038/nrneurol.2013.278.PubMedCentralCrossRefPubMed Jeste SS, Geschwind DH: Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol. 2014, 10: 74-81. 10.1038/nrneurol.2013.278.PubMedCentralCrossRefPubMed
2.
go back to reference Carvill GL, Mefford HC: Microdeletion syndromes. Curr Opin Genet Dev. 2013, 23: 232-239. 10.1016/j.gde.2013.03.004.CrossRefPubMed Carvill GL, Mefford HC: Microdeletion syndromes. Curr Opin Genet Dev. 2013, 23: 232-239. 10.1016/j.gde.2013.03.004.CrossRefPubMed
3.
go back to reference Carr EG, Owen-Deschryver JS: Physical illness, pain, and problem behavior in minimally verbal people with developmental disabilities. J Autism Dev Disord. 2007, 37: 413-424. 10.1007/s10803-006-0176-0.CrossRefPubMed Carr EG, Owen-Deschryver JS: Physical illness, pain, and problem behavior in minimally verbal people with developmental disabilities. J Autism Dev Disord. 2007, 37: 413-424. 10.1007/s10803-006-0176-0.CrossRefPubMed
4.
go back to reference Akins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, Hansen RL: Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr. 2014, 35: 1-10. 10.1097/DBP.0000000000000013.PubMedCentralCrossRefPubMed Akins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, Hansen RL: Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr. 2014, 35: 1-10. 10.1097/DBP.0000000000000013.PubMedCentralCrossRefPubMed
5.
go back to reference Hendren RL: Autism: biomedical complementary treatment approaches. Child Adolesc Psychiatr Clin N Am. 2013, 22: 443-456. 10.1016/j.chc.2013.03.002. viCrossRefPubMed Hendren RL: Autism: biomedical complementary treatment approaches. Child Adolesc Psychiatr Clin N Am. 2013, 22: 443-456. 10.1016/j.chc.2013.03.002. viCrossRefPubMed
6.
go back to reference Rossignol DA: Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009, 21: 213-236.PubMed Rossignol DA: Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009, 21: 213-236.PubMed
7.
go back to reference Jyonouchi H, Geng L, Streck DL, Toruner GA: Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes. J Neuroimmunol. 2011, 238: 73-80. 10.1016/j.jneuroim.2011.07.001.CrossRefPubMed Jyonouchi H, Geng L, Streck DL, Toruner GA: Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes. J Neuroimmunol. 2011, 238: 73-80. 10.1016/j.jneuroim.2011.07.001.CrossRefPubMed
8.
go back to reference Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008, 5: 52-10.1186/1742-2094-5-52.PubMedCentralCrossRefPubMed Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008, 5: 52-10.1186/1742-2094-5-52.PubMedCentralCrossRefPubMed
9.
go back to reference Jyonouchi H, Geng L, Streck DL, Toruner GA: Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation. 2012, 9: 4-10.1186/1742-2094-9-4.PubMedCentralCrossRefPubMed Jyonouchi H, Geng L, Streck DL, Toruner GA: Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation. 2012, 9: 4-10.1186/1742-2094-9-4.PubMedCentralCrossRefPubMed
10.
go back to reference Rebane A, Akdis CA: MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol. 2013, 132: 15-26. 10.1016/j.jaci.2013.04.011.CrossRefPubMed Rebane A, Akdis CA: MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol. 2013, 132: 15-26. 10.1016/j.jaci.2013.04.011.CrossRefPubMed
11.
go back to reference Guedes J, Cardoso AL, De Lima MC P: Involvement of microRNA in microglia-mediated immune response. Clin Dev Immunol. 2013, 2013: 186872-10.1155/2013/186872.PubMedCentralCrossRefPubMed Guedes J, Cardoso AL, De Lima MC P: Involvement of microRNA in microglia-mediated immune response. Clin Dev Immunol. 2013, 2013: 186872-10.1155/2013/186872.PubMedCentralCrossRefPubMed
12.
go back to reference Tse MT: Neuroimmunology: uncovering new roles for microRNAs and TLRs. Nat Rev Neurosci. 2012, 13: 448-10.1038/nrn3276.CrossRefPubMed Tse MT: Neuroimmunology: uncovering new roles for microRNAs and TLRs. Nat Rev Neurosci. 2012, 13: 448-10.1038/nrn3276.CrossRefPubMed
13.
go back to reference Swedo SE, Leckman JF, Rose NR: From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Peditrics Ther. 2012, 2: 113. Swedo SE, Leckman JF, Rose NR: From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Peditrics Ther. 2012, 2: 113.
14.
go back to reference Jyonouchi H: Non-IgE mediated food allergy - update of recent progress in mucosal immunity. Inflamm Allergy Drug Targets. 2012, 11: 382-396. 10.2174/187152812803250971.CrossRefPubMed Jyonouchi H: Non-IgE mediated food allergy - update of recent progress in mucosal immunity. Inflamm Allergy Drug Targets. 2012, 11: 382-396. 10.2174/187152812803250971.CrossRefPubMed
15.
go back to reference Aman MG, Singh NN, Stewart AW, Field CJ: The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985, 89: 485-491.PubMed Aman MG, Singh NN, Stewart AW, Field CJ: The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985, 89: 485-491.PubMed
16.
go back to reference Owens JA, Spirito A, McGuinn M: The children’s sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000, 23: 1043-1051.PubMed Owens JA, Spirito A, McGuinn M: The children’s sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000, 23: 1043-1051.PubMed
17.
go back to reference Sparrow SBCD, Vineland DV: Adaptive behavior scales survey form manual. Am Guid Serv. 1985, 1985: 1985. Sparrow SBCD, Vineland DV: Adaptive behavior scales survey form manual. Am Guid Serv. 1985, 1985: 1985.
18.
go back to reference Breau LM, McGrath PJ, Camfield CS, Finley GA: Psychometric properties of the non-communicating children’s pain checklist-revised. Pain. 2002, 99: 349-357. 10.1016/S0304-3959(02)00179-3.CrossRefPubMed Breau LM, McGrath PJ, Camfield CS, Finley GA: Psychometric properties of the non-communicating children’s pain checklist-revised. Pain. 2002, 99: 349-357. 10.1016/S0304-3959(02)00179-3.CrossRefPubMed
19.
go back to reference Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfild L, Furuta TG, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM: Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010, 126: S1-S58. 10.1016/j.jaci.2010.10.008.PubMedCentralCrossRefPubMed Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfild L, Furuta TG, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM: Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010, 126: S1-S58. 10.1016/j.jaci.2010.10.008.PubMedCentralCrossRefPubMed
20.
go back to reference Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, et al: Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011, 128: 3-20. 10.1016/j.jaci.2011.02.040. e26. quiz 21-22CrossRefPubMed Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, et al: Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011, 128: 3-20. 10.1016/j.jaci.2011.02.040. e26. quiz 21-22CrossRefPubMed
21.
go back to reference Butrus S, Portela R: Ocular allergy: diagnosis and treatment. Ophthalmol Clin North Am. 2005, 18: 485-492. v. ReviewPubMed Butrus S, Portela R: Ocular allergy: diagnosis and treatment. Ophthalmol Clin North Am. 2005, 18: 485-492. v. ReviewPubMed
22.
go back to reference Nassef M, Shapiro G, Casale TB: Identifying and managing rhinitis and its subtypes: allergic and nonallergic components-a consensus report and materials from the Respiratory and Allergic Disease Foundation. Curr Med Res Opin. 2006, 22: 2541-2548. 10.1185/030079906X158057.CrossRefPubMed Nassef M, Shapiro G, Casale TB: Identifying and managing rhinitis and its subtypes: allergic and nonallergic components-a consensus report and materials from the Respiratory and Allergic Disease Foundation. Curr Med Res Opin. 2006, 22: 2541-2548. 10.1185/030079906X158057.CrossRefPubMed
23.
go back to reference Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007, 120: S94-S138. 10.1016/j.jaci.2007.09.029. Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007, 120: S94-S138. 10.1016/j.jaci.2007.09.029.
24.
go back to reference Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, Kumararatne D, Harville TO, Hesterberg P, Koleilat M, McGhee S, Perez EE, Raasch J, Scherzer R, Schroeder H, Seroogy C, Huissoon A, Sorensen RU, Katial R: Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the american academy of allergy, asthma & immunology. J Allergy Clin Immunol. 2012, 130: S1-S24. 10.1016/j.jaci.2012.07.002.CrossRefPubMed Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, Kumararatne D, Harville TO, Hesterberg P, Koleilat M, McGhee S, Perez EE, Raasch J, Scherzer R, Schroeder H, Seroogy C, Huissoon A, Sorensen RU, Katial R: Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the american academy of allergy, asthma & immunology. J Allergy Clin Immunol. 2012, 130: S1-S24. 10.1016/j.jaci.2012.07.002.CrossRefPubMed
25.
go back to reference Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B: Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005, 51: 77-85. 10.1159/000084164.CrossRefPubMed Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B: Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005, 51: 77-85. 10.1159/000084164.CrossRefPubMed
26.
go back to reference Enstrom AM, Onore CE, Van de Water JA, Ashwood P: Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010, 24: 64-71. 10.1016/j.bbi.2009.08.001.PubMedCentralCrossRefPubMed Enstrom AM, Onore CE, Van de Water JA, Ashwood P: Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010, 24: 64-71. 10.1016/j.bbi.2009.08.001.PubMedCentralCrossRefPubMed
27.
go back to reference Benros ME, Mortensen PB, Eaton WW: Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012, 1262: 56-66. 10.1111/j.1749-6632.2012.06638.x.CrossRefPubMed Benros ME, Mortensen PB, Eaton WW: Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012, 1262: 56-66. 10.1111/j.1749-6632.2012.06638.x.CrossRefPubMed
28.
go back to reference Meyer U, Feldon J, Dammann O: Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res. 2011, 69: 26R-33R. 10.1203/PDR.0b013e318212c196.PubMedCentralCrossRefPubMed Meyer U, Feldon J, Dammann O: Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res. 2011, 69: 26R-33R. 10.1203/PDR.0b013e318212c196.PubMedCentralCrossRefPubMed
29.
30.
go back to reference Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011, 70: 663-671. 10.1016/j.biopsych.2011.04.013.PubMedCentralCrossRefPubMed Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011, 70: 663-671. 10.1016/j.biopsych.2011.04.013.PubMedCentralCrossRefPubMed
31.
go back to reference Watanabe Y, Someya T, Nawa H: Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci. 2010, 64: 217-230. 10.1111/j.1440-1819.2010.02094.x.CrossRefPubMed Watanabe Y, Someya T, Nawa H: Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci. 2010, 64: 217-230. 10.1111/j.1440-1819.2010.02094.x.CrossRefPubMed
32.
go back to reference Josefowicz SZ, Lu LF, Rudensky AY: Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012, 30: 531-564. 10.1146/annurev.immunol.25.022106.141623.CrossRefPubMed Josefowicz SZ, Lu LF, Rudensky AY: Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012, 30: 531-564. 10.1146/annurev.immunol.25.022106.141623.CrossRefPubMed
33.
go back to reference Lechtenberg BC, Mace PD, Riedl SJ: Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol. 2014, 29C: 17-25. 10.1016/j.sbi.2014.08.011.CrossRef Lechtenberg BC, Mace PD, Riedl SJ: Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol. 2014, 29C: 17-25. 10.1016/j.sbi.2014.08.011.CrossRef
34.
go back to reference Federici S, Martini A, Gattorno M: The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013, 4: 351-10.3389/fimmu.2013.00351.PubMedCentralCrossRefPubMed Federici S, Martini A, Gattorno M: The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013, 4: 351-10.3389/fimmu.2013.00351.PubMedCentralCrossRefPubMed
35.
go back to reference Tanaka T, Narazaki M, Ogata A, Kishimoto T: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol. 2014, 26: 88-96. 10.1016/j.smim.2014.01.009. Volume 8CrossRefPubMed Tanaka T, Narazaki M, Ogata A, Kishimoto T: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol. 2014, 26: 88-96. 10.1016/j.smim.2014.01.009. Volume 8CrossRefPubMed
36.
go back to reference Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, Yoshida H, Nishikawa T, Terabe F, Ohkawara T, Takahashi T, Ripley B, Kimura A, Kishimoto T, Naka T: IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008, 105: 9041-9046. 10.1073/pnas.0802218105.PubMedCentralCrossRefPubMed Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, Yoshida H, Nishikawa T, Terabe F, Ohkawara T, Takahashi T, Ripley B, Kimura A, Kishimoto T, Naka T: IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008, 105: 9041-9046. 10.1073/pnas.0802218105.PubMedCentralCrossRefPubMed
37.
go back to reference Smith SE, Li J, Garbett K, Mirnics K, Patterson PH: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007, 27: 10695-10702. 10.1523/JNEUROSCI.2178-07.2007.PubMedCentralCrossRefPubMed Smith SE, Li J, Garbett K, Mirnics K, Patterson PH: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007, 27: 10695-10702. 10.1523/JNEUROSCI.2178-07.2007.PubMedCentralCrossRefPubMed
38.
go back to reference Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM: LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Beta levels in adult rat offspring: relevance to autism. PLoS One. 2013, 8: e82244-10.1371/journal.pone.0082244.PubMedCentralCrossRefPubMed Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM: LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Beta levels in adult rat offspring: relevance to autism. PLoS One. 2013, 8: e82244-10.1371/journal.pone.0082244.PubMedCentralCrossRefPubMed
39.
go back to reference Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev. 2010, 21: 331-344. 10.1016/j.cytogfr.2010.09.002.CrossRefPubMed Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev. 2010, 21: 331-344. 10.1016/j.cytogfr.2010.09.002.CrossRefPubMed
Metadata
Title
Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?
Authors
Harumi Jyonouchi
Lee Geng
Amy L Davidow
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2014
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-014-0187-2

Other articles of this Issue 1/2014

Journal of Neuroinflammation 1/2014 Go to the issue